Retinal vein occlusions: The potential impact of a dysregulation of the retinal veins.
A retinal vein occlusion (RVO) is a sight threatening disease. It can be divided into central vein occlusion and branch retinal vein occlusion. The pathogenesis of the condition remains to be solved. Mechanical compression of the vessel wall or thrombotic occlusion of the vessel lumen, sometimes combined with rheological disorders, are often assumed pathomechanisms. Accordingly, the therapy relies either on mechanical decompression, lyses of thrombi or improvement of rheology. A number of observations however, such as the relationship of RVO to atherosclerotic risk factors, spontaneous reversibility particularly in young patients, rest flow observed in angiography, occlusion despite anticoagulation or thrombocytopenia and finally the positive effect of anti-VEGF therapy are not explained by the present pathogenetic concept. As a new concept we propose a local venous constriction induced by vasoconstrictive molecules diffusing from neighbouring diseased arteries and/or from other neighbouring (hypoxic) tissues. Recognizing these postulated conditions might lead to an earlier identification of impending vein occlusions as well as to a treatment more tailored to the risk factor constellation of the particular patient.
Department of Ophthalmology, University of Basel, Mittlere Strasse 91, 4031 Basel, Switzerland.
Stephan A
SA
Fraenkl
Maneli
M
Mozaffarieh
Josef
J
Flammer
Arch Ophthalmol. 1982 Jul;100(7):1132-40
6178389
Am J Ophthalmol. 1950 Feb;33(2):175-84, illust
15405336
Am J Physiol Heart Circ Physiol. 2003 Nov;285(5):H2225-32
12842810
Ophthalmology. 2004 Aug;111(8):1489-94
15288976
Am J Ophthalmol. 2005 Aug;140(2):256-61
16086947
J Fr Ophtalmol. 2007 Feb;30(2):145-9
17318096
Graefes Arch Clin Exp Ophthalmol. 2003 May;241(5):367-70
12698255
Exp Physiol. 2007 Jan;92(1):21-6
17124275
Graefes Arch Clin Exp Ophthalmol. 2002 Mar;240(3):180-96
11935275
Prog Retin Eye Res. 2001 May;20(3):319-49
11286896
Invest Ophthalmol Vis Sci. 2008 Oct;49(10):4297-302
18539932
Ophthalmology. 1999 Nov;106(11):2054-62
10571337
Br J Ophthalmol. 1999 Jan;83(1):127-8
10209457
Graefes Arch Clin Exp Ophthalmol. 1993 Aug;231(8):476-81
8224948
Aust N Z J Ophthalmol. 1993 Nov;21(4):213-7
8148137
Am J Ophthalmol. 1994 Feb 15;117(2):211-3
8116749
Surv Ophthalmol. 2007 Nov;52 Suppl 2:S115-21
17998035
Arch Ophthalmol. 2004 Sep;122(9):1348-56
15364715
Prog Retin Eye Res. 2008 Jul;27(4):331-71
18653375
Eur J Ophthalmol. 1995 Apr-Jun;5(2):88-91
7549448
J Cell Biochem. 1991 Nov;47(3):219-23
1791186
Ophthalmology. 1999 May;106(5):1009-12
10328405
Arch Ophthalmol. 1989 Jul;107(7):998-1000
2751472
J Glaucoma. 2007 Dec;16(8):645-8
18091448
Prog Retin Eye Res. 2008 Nov;27(6):622-47
18940262
Ophthalmology. 2004 Jun;111(6):1196-200
15177971
Ophthalmology. 1993 Mar;100(3):423-8
8460014
Graefes Arch Clin Exp Ophthalmol. 1995 Aug;233(8):484-8
8537023
Am J Cardiol. 1998 Aug 6;82(3A):8H-14H
9719016
Trans Am Ophthalmol Soc. 2000;98:133-41; discussion 141-3
11190017
Eye (Lond). 2009 May;23(5):1066-71
18670462
Endothelium. 1997;5(2):115-8
9237045
Ophthalmology. 2008 Nov;115(11):2049-57
18672290
Am J Ophthalmol. 1990 Mar 15;109(3):298-302
2309862
Br J Ophthalmol. 2002 Nov;86(11):1299-302
12386093
Korean J Ophthalmol. 2007 Dec;21(4):222-7
18063887
Graefes Arch Clin Exp Ophthalmol. 2005 Apr;243(4):334-8
15744527
Invest Ophthalmol Vis Sci. 2006 Sep;47(9):4034-41
16936120
Eye (Lond). 2008 Jan;22(1):120-7
17072289
Graefes Arch Clin Exp Ophthalmol. 1997 Oct;235(10):634-8
9349947
Graefes Arch Clin Exp Ophthalmol. 2005 Jul;243(7):659-64
15672253
N Engl J Med. 1991 Oct 3;325(14):997-1001
1886637
Graefes Arch Clin Exp Ophthalmol. 1997 Jan;235(1):10-3
9034836
Mol Vis. 2008 Aug 29;14:1584-8
18769648
Pharmacol Res. 2005 Jan;51(1):41-50
15519534
Ophthalmologica. 1953 Dec;126(6):329-47
13133324
Thromb Haemost. 2005 Jun;93(6):1021-6
15968383
Klin Monbl Augenheilkd. 2004 May;221(5):357-9
15162279
Am J Ophthalmol. 1994 Jan 15;117(1):72-80
8291596
Ophthalmology. 1998 May;105(5):765-71
9593373
Retina. 2007 Jan;27(1):49-54
17218915
Int Ophthalmol. 1992 Sep;16(4-5):235-8
1428549
Surv Ophthalmol. 1978 May-Jun;22(6):357-76
354066
Clin Exp Ophthalmol. 2009 Jul;37(5):490-5
19624346
J Glaucoma. 1999 Jun;8(3):212-9
10376264
Cardiovasc Res. 2007 Sep 1;75(4):702-9
17391658
Clin Exp Pharmacol Physiol. 1999 Jan;26(1):74-84
10027074
Curr Opin Ophthalmol. 2008 May;19(3):234-8
18408499
Klin Monbl Augenheilkd. 1996 May;208(5):303-5
8766034
Am J Ophthalmol. 2001 Jan;131(1):61-77
11162981
Klin Monbl Augenheilkd. 2001 May;218(5):366-9
11417338
J Glaucoma. 1996 Feb;5(1):22-8
8795730
Arch Ophthalmol. 1996 Oct;114(10):1243-7
8859084
Trans Ophthalmol Soc U K. 1969;88:191-210
5272252
Acta Ophthalmol Scand. 2006 Feb;84(1):62-8
16445441
Ophthalmology. 1998 Mar;105(3):424-7
9499771
Prog Retin Eye Res. 2005 Jul;24(4):493-519
15845346
Arch Ophthalmol. 1991 May;109(5):705-9
1755868
Buch Augenarzt. 1962;40:1-175
13992656
Br J Ophthalmol. 1974 May;58(5):548-54
4422248
Angiology. 1990 Mar;41(3):213-20
2310050
Am J Ophthalmol. 1994 Oct 15;118(4):445-50
7943121
Br J Ophthalmol. 1998 May;82(5):498-503
9713055
J Fr Ophtalmol. 2009 Jun;32(6):420-4
19523714
Acta Ophthalmol Scand. 2004 Dec;82(6):738-40
15606473
N Engl J Med. 1986 Oct 23;315(17):1046-51
3093861
Acta Ophthalmol. 2009 Sep;87(6):638-42
18631327
Invest Ophthalmol Vis Sci. 1990 Feb;31(2):284-9
2303330